Kathleen McElhone

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Richard B. Warren, Catherine Smith, Zenas Z N Yiu et al. · Journal of Investigative Dermatology · 2015 · 366 citations

British Association, Clinical Epidemiology, Clinical Dermatology +6

Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus

Kathleen McElhone, Janice Abbott, J. Shelmerdine et al. · Arthritis Care & Research · 2007 · 330 citations · Full text

Psychological Distress Impairs Clearance of Psoriasis in Patients Treated With Photochemotherapy

Dónal G. Fortune, Helen L. Richards, Brian Kirby et al. · Archives of Dermatology · 2003 · 243 citations

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand, Michael Duckworth, David Baudry et al. · Journal of Allergy and Clinical Immunology · 2018 · 162 citations · Full text

Autoimmune Disease, Medicine, Biologic Treatment Response +9

Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study

Kathleen McElhone, Janice Abbott, Julie McLaughlin Gray et al. · Lupus · 2010 · 122 citations · Full text